Please use this identifier to cite or link to this item: https://cris.library.msu.ac.zw//handle/11408/6667
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMusuka Godfreyen_US
dc.contributor.authorDiego F. Cuadrosen_US
dc.contributor.authorMiller F. DeWolfeen_US
dc.contributor.authorZindoga Mukandavireen_US
dc.contributor.authorDhliwayo Tapiwaen_US
dc.contributor.authorPatrick Gad Iradukundaen_US
dc.contributor.authorOscar Manoen_US
dc.contributor.authorTafadzwa Dzinamariraen_US
dc.date.accessioned2025-08-03T13:06:19Z-
dc.date.available2025-08-03T13:06:19Z-
dc.date.issued2025-
dc.identifier.urihttps://cris.library.msu.ac.zw//handle/11408/6667-
dc.description.abstractBackground: Children with disabilities, particularly in low- and middle-income countries (LMICs), face heightened risks of vaccine-preventable diseases due to a range of systemic and social barriers. Although immunization is a fundamental human right and a proven public health intervention, this vulnerable group is often overlooked in policy and practice. Understanding the factors compromising vaccine equity for these children is critical to reducing zero-dose prevalence and improving health outcomes. Methods: This scoping review examined peer-reviewed, gray literature from 2010 to 2024. Searches were conducted in PubMed, Google Scholar, and relevant organizational reports (WHO, UNICEF). Studies addressing children with disabilities and focusing on immunization barriers, interventions, or lessons learned were selected. English-language publications were screened in title/abstract and full-text stages. Key data extracted included population, barriers, and immunization outcomes. Since this review focused on articles in English, this is a key limitation. Results were synthesized thematically to identify recurring patterns and to guide improved interventions and policies. Results: Twelve articles met the inclusion criteria. Key barriers identified were inadequate healthcare infrastructure, insufficient provider training, limited follow-up services in rural regions, societal stigma, and pervasive misconceptions around both disability and vaccines. Factors such as maternal education, logistical support for caregivers, and using low-sensory, inclusive vaccination settings were consistently linked with better outcomes. Effective strategies included mobile vaccination units, tailored interventions (e.g., distraction or sedation techniques), school-based immunization programs, and robust community engagement to address stigma. Lessons learned underscored the importance of flexible, individualized care plans and empowering families through transparent communication. Conclusions: Children with disabilities continue to experience significant gaps in immunization coverage, driven by intersecting barriers at the individual, health system, and societal levels. Scaling tailored interventions, inclusive policies, strengthened infrastructure, and ongoing research can help ensure these children receive equitable access to life-saving vaccinations.en_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.relation.ispartofVaccinesen_US
dc.subjectImmunization equityen_US
dc.subjectChildren with disabilitiesen_US
dc.subjectLow- and middle-income countriesen_US
dc.subjectVaccine barriersen_US
dc.subjectVaccination strategiesen_US
dc.subjectInclusive healthcareen_US
dc.titleImmunization Coverage, Equity, and Access for Children with Disabilities: A Scoping Review of Challenges, Strategies, and Lessons Learned to Reduce the Number of Zero-Dose Childrenen_US
dc.typeresearch articleen_US
dc.identifier.doihttps://doi.org/10.3390/vaccines13040377-
dc.contributor.affiliationInternational Initiative for Impact Evaluation, Harare P.O. Box 0002, Zimbabween_US
dc.contributor.affiliationDigital Epidemiology Laboratory, Digital Futures, University of Cincinnati, Cincinnati, OH 45221, USAen_US
dc.contributor.affiliationDepartment of Tropical Medicine and Medical Microbiology and Pharmacology, University of Hawaii at Manoa, Honolulu, HI 96822, USAen_US
dc.contributor.affiliationInstitute of Applied Research and Technology, Emirates Aviation University, Dubai P.O. Box 53044, United Arab Emiratesen_US
dc.contributor.affiliationDepartment of Community Medicine, Midlands State University, Gweru P.O. Box 9055, Zimbabween_US
dc.contributor.affiliationRwanda Food and Drug Authority, Kigali P.O. Box 3243, Rwandaen_US
dc.contributor.affiliationDepartment of Public Health, University of the Western Cape, Robert Sobukwe Road, Bellville 7535, South Africaen_US
dc.contributor.affiliationSchool of Health Systems and Public Health, University of Pretoria, Pretoria 0002, South Africa; ICAP in Zimbabwe, Harare P.O. Box 263, Zimbabween_US
dc.relation.issn2076-393Xen_US
dc.description.volume13en_US
dc.description.issue4en_US
item.grantfulltextopen-
item.fulltextWith Fulltext-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetyperesearch article-
Appears in Collections:Research Papers
Files in This Item:
File Description SizeFormat 
vaccines-13-00377.pdfFulltext878.49 kBAdobe PDFView/Open
Show simple item record

Page view(s)

26
checked on Aug 6, 2025

Google ScholarTM

Check

Altmetric


Items in MSUIR are protected by copyright, with all rights reserved, unless otherwise indicated.